Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of gevokizumab in Behçet's disease uveitis
2012-001125-27Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Behçet's disease (BD) comparing gevokizumab + standard of care with placebo + standard of care (2 arms). Primary endpoint: Time to first acute ocular exacerbation. Started Sep 2012; status: completed.
02
Drugs
gevokizumab
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on 2012-001125-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001125-27.